Trial Profile
Comparison of the Efficacy of Annual Zoledronic Acid or Weekly Alendronate. a 3-Yr Analysis of Postmenopausal Women with Low Bone Mineral Density
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2012
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Zoledronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 04 Jul 2012 New trial record